Swiss Cannabis Pharmacies: What the Pharma Model Means for Accessories Retailers

# Swiss Cannabis Pharmacies: What the Pharma Model Means for Accessories Retailers

Switzerland is no longer a side market for cannabis accessories. The Züri-Can pilot program has been extended to October 2028 — the Zurich City Council voted in favor on March 18, 2026, with a vote of 101:13. The data is now robust: 114,200 legal transactions, 972 kg of cannabis sold, approximately CHF 10 million withdrawn from the black market. But the crucial difference to the German model lies elsewhere: cannabis is distributed through pharmacies in Switzerland. This fundamentally changes the requirements for accessories.

Which products do the 2,424 registered participants actually buy in pharmacies? What distinguishes the demand from the German CSC model? And what does a pharmaceutical framework mean for your product range?

Züri Can: 2,424 Participants, 114,200 Sales, 972 kg

The Züri-Can project of the University of Zurich provides the most solid primary data on the Swiss model. Since September 2022, 2,424 participants have been registered, 114,200 sales made, and 972 kg of cannabis distributed in 194,321 individual packages. The average CUD rate (Cannabis Use Disorder) decreased from 25% at the start of the study to 20% — a statistically significant effect confirmed by the NZZ in its interim report on May 6, 2026.

Extension to 2028: 101:13 in the City Council

On March 18, 2026, the Zurich City Council voted by a clear majority for the extension to October 2028 and approved an additional CHF 800,000. The only dissenting vote came from the SVP — even conservative circles now consider the scientific evidence sufficient. The SP faction demanded during the same debate that vapes, edibles, and e-liquids be included in the program (Business of Cannabis, April 2, 2026). A national cannabis law is not expected before 2027.

10 Pharmacies, 9 Social Clubs, 1 DIZ — Three Models Compared

Three of the seven national pilot projects explicitly test the pharmacy model:

| Project | Location | Model | |---------|----------|-------| | Züri Can | Zurich | Pharmacies + Social Clubs + DIZ | | SCRIPT | Bern, Biel, Lucerne | Pharmacies | | WeedCare | Basel-Stadt | Pharmacies |

In total, there are 21 points of supply: 10 pharmacies, 9 cannabis social clubs, and 1 drug information center (DIZ). Pharmacies are thus the largest distribution channel — and the one with the highest product requirements.

Approximately CHF 10 Million Withdrawn from Black Market

NZZ estimates the black market reduction at around CHF 10 million, based on 1,000 kg × CHF 10,000/kg. The UZH itself does not provide a black market estimate — its strength lies in the objective sales data (114,200 transactions, 972 kg). The City of Zurich was still at CHF 7.5 million in October 2025 — so the project has significantly increased in volume.

Product Range Expanded from 5 to 14 Strains

The product range has been expanded from 5 to 14 strains. This means more differentiation, but also a greater need for assortment-specific accessories — from different container sizes to product-specific vaporizer temperatures.

Pharmacy Model vs. CSC Model: A Comparison for Retailers

Anyone entering the cannabis accessories business today must understand the differences between the European models. Because each model generates a different product demand.

| Dimension | Germany (CSC) | Switzerland (Pharmacy) | Netherlands (Coffeeshop) | |-----------|---------------|------------------------|--------------------------| | Distribution Channel | Non-profit club, club membership | Pharmacy, medical accompaniment | Specialty store, age verification | | Price Level | Capped, club fee | Higher, medically regulated | Market price, tourism-driven | | Accessories Demand | Grinders, Papers, Storage | Medical vaporizers, dosing aids, pharma containers | Papers, Grinders, Vaporizers | | Compliance Requirement | Association law, CanG | Therapeutic Products Act, Medical Devices Ordinance | Tolerance framework, local policy |

What this means for retailers: In the pharmacy model, products that meet medical standards are in demand. No pure price competition — quality and compliance decide.

Germany: CSCs as Non-Profit Clubs

German cannabis social clubs are association structures. Members pay fees and receive cannabis at capped prices. Accessories are usually bought privately — the club has no product responsibility. The German model is consumption-oriented, not medical.

Switzerland: Pharmacies as Medical Distribution Points

Swiss pharmacies are subject to the Therapeutic Products Act. Each delivery is documented, each product choice requires intensive consultation. Staff are trained (IDPC/FOPH Analysis Report, February 2026). For accessories, this means: Products must be pharmacy-ready — CE marking, pharmaceutical packaging, traceable supply chain.

Netherlands: Coffeeshops as Specialty Stores

The Dutch market is the most established, but also the most uncertain (no fully legal framework outside the Gedoogbeleid). Coffeeshops buy accessories like headshops — price-sensitive, trend-driven, convenience-oriented.

What Do Participants Buy in Cannabis Pharmacies?

The sales data from Züri Can (114,200 transactions) provide a good insight into what is really needed.

Vaporizers: Medical Gold Standard

The FOPH/IDPC analysis report confirms a growing trend towards lower-risk consumption methods. Vaporizers are the medical standard — no combustion, adjustable temperatures, reduced pollutant exposure. The SP faction explicitly demanded vapes in the program. Unlike in the German CSC model, where members bring their own vaporizers or buy them privately, Swiss pharmacies rely on consultation-supported sales: The customer expects a professional recommendation, not self-service. For retailers, this means: medical vaporizers with CE marking, calibrated temperature control, and pharmacy-compatible packaging are the product category with the greatest growth potential in the pharma channel.

Dosing Aids and Micro-Dosers

The reduction in CUD from 25% to 20% is no coincidence. The pharmacy model promotes dosed, controlled consumption. Micro-dosers, precision scales, and dosing capsules are products that can be sold in pharmacies — not in headshops. That is a market gap.

Airtight Containers and Storage Solutions

194,321 packages were sold in 5g units. This creates a massive demand for airtight, odor-proof storage solutions — pharmacy format, not headshop aesthetics. Products with BPA-free materials, child-resistant closures, and pharmaceutical design are in demand.

Smoking Accessories: Papers, Grinders — Remain Relevant

The main form of consumption remains smoking. Papers, grinders, and filters are still in demand — but with higher quality requirements than in the recreational market. Pharmacies do not sell low-budget accessories.

NEW: Edibles and E-Liquids

The city council debate from March 2026 made it clear: The demand for vapes, edibles, and e-liquids is increasing. They are not yet included in the program, but political pressure is growing. Retailers should include edibles packaging, e-liquid accessories, and vaporizers for liquid extracts in their product roadmap now.

The Numbers for Accessories Retailers

Projected: With 10,400 participants and an average accessories turnover of CHF 50–100 per person per year, a market of CHF 0,